Information about Primary Pulmonary Hypertension and other forms of Severe Pulmonary Hypertension


PPH NEWS is an education-based resource site that provides information on the health issues surrounding Primary Pulmonary Hypertension (PPH), including what it is, the symptoms, diagnoses, and treatment options.
This website also provides resource to learn more about your legal rights and remedies if you or someone you know has developed PPH due to the use of diet drugs such as Fen Phen.

Get a FREE Evaluation

Select your state to
contact a PPH Lawyer

Flolan

Approved by the FDA in 1995 for the treatment of PPH, Flolan, or epoprostenol, is extremely effective in opening up blood vessels in the lungs and throughout the body. Flolan is a form of a naturally occurring molecule in the human body called prostaglandin. Using Flolan prevents blood clots by removing the buildup of lipids, and lowering blood pressure. A dose of Flolan lasts only three to five minutes, so users receive the medication intravenously through a catheter connected to a pump that continuously infuses the lungs with Flolan. Patients must wear a battery operated backpack or bag that keeps the drug at the proper temperature; Flolan is very sensitive to heat and sunlight. Patients who undergo Flolan therapy can extend their life expectancy by three to five years or more.

Although currently the only treatment for PPH with full FDA approval, Flolan has several drawbacks. First, the drug, while extremely effective, must be constantly replaced in the bloodstream. Flolan is a lifelong therapy that cannot be interrupted—even a brief interruption of the infusion of Flolan can result in a sudden reoccurrence of symptoms. The system used to deliver Flolan requires careful maintenance and special training, including home health care services to learn about administering this treatment. Flolan is extremely expensive, with the average course of treatment costing well over $100,000 annually. Flolan side effects include jaw pain, headache, flushing, nausea, diarrhea, and vomiting. The indwelling catheter used to deliver Flolan is permanently inserted into the neck or chest, and requires a high degree of maintenance, since infections can be serious.

Flolan offers hope to many PPH patients, especially those waiting for a lung transplant. Although treatment with Flolan is a complicated, expensive, and somewhat risky procedure, the potential to gain a few years may mean the difference between death and a lifesaving lung transplant. Alternatives to Flolan such as Tracleer (bosentan) and Remodulin (UT-15) may soon replace this treatment, and in the meantime, PPH victims may be able to recover the costs of Flolan treatment from the manufacturers of diet drugs such as Fen Phen. If you or a loved one is currently taking Flolan for PPH that you believe may be linked to the use of diet drugs, contact an attorney to learn more about your legal rights.

Learn More about these medications used to treat Pulmonary Hypertension:

» Tracleer
» Remodulin
» Flolan

FREE Case Evaluation by clicking on your state below:

 

SELECT YOUR STATE TO CONTACT A PPH LAWYER
Alabama Alaska Arizona Arkansas
California Colorado Connecticut Delaware
Florida Georgia Hawaii Idaho
Illinois Indiana Iowa Kansas
Kentucky Louisiana Maine Maryland
Massachusetts Michigan Minnesota Mississippi
Missouri Montana Nebraska Nevada
New Hampshire New Jersey New Mexico New York
North Carolina North Dakota Ohio Oklahoma
Oregon Pennsylvania Puerto Rico Rhode Island
South Carolina South Dakota Tennessee Texas
Utah Vermont Virginia Washington
Washington DC West Virginia Wisconsin Wyoming

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

top

Home

Legal Issues

PPH FAQ's

PPH Explained

Causes

Case

Injury

Settlement

Symptoms

Diagnosing PPH

Diagnosis

Treatment

Medications

Pulmonary Hypertension

What is Fen Phen

Problems Associated
with Fen Phen

Fen Phen and PPH

Fen Phen and Heart Disease

Fen Phen/Legal Rights

PPh Lawsuits

FDA Withdrawal

News

History

Links

 

Learn More About PPH Treatments:
» Remodulin
» Flolan
» Tracleer


Patients suffering from Primary Pulmonary Hypertension (PPH) caused by Fen-Phen, Pondimin or Redux are not included in the Nationwide Class Action Settlement Agreement with American Home Products.  PPH patients must file independent lawsuits to make legal claims.  To learn your legal rights, please contact us and speak with a PPH Lawyer for lawsuit information!